Digital Therapeutics (DTx), a subset of Digital Health, delivers evidence-based therapeutic interventions that are driven by high-quality software programs. It can be used for treating, managing, or improving health for a wide range of diseases and disorders like diabetes, anxiety, post-traumatic stress disorder, asthma, etc. The digital therapeutics industry is evolving and is grabbing the attention of multiple stakeholders in the healthcare and life science industry.

This playbook aims to be a go-to knowledge stop for all stakeholders that are exploring the digital therapeutics space.

The playbook covers all of the stages of DTx solution development which include ideation, product development, clinical evaluation, regulatory approval, and commercialization. It covers case studies of DTx startups to help understand the nuances of developing a DTx solution.

The playbook synthesizes intelligence from secondary research, literature review, and interviews with multiple industry stakeholders.